Latest Breaking News On - Kuros biosciences - Page 8 : comparemela.com

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA

In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal fusion in a difficult-to-treat real life patient population (20% smokers). In the STRUCTURE trial, MagnetOs mixed with autograft showed posterolateral fusion rates comparable to autograft fusion rates in the le.

United statesKuros biosciencesDaniel geigerVan dijkSwiss exchangeChief executive officerBiomed mater

Adhoc: Kuros Biosciences AG: Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA

Adhoc: Kuros Biosciences AG: Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesKuros biosciencesVan dijkDaniel geigerStefan klotterSwiss exchangeNews serviceBiosciences announces resultsTwo prospective randomized clinical trialsChief executive officerBiomed materLassen sie

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.

United statesKuros biosciencesVan dijkSwiss exchangeChief executive officerBiomed mater

Orthobiologics Market size to grow by USD 2 64 billion from 2022-2027, North America to account for 41% of market growth

/PRNewswire/ The orthobiologics market size is expected to grow by USD 2.64 billion from 2022 to 2027. In addition, the momentum of the market will progress.

United kingdomUnited statesJesse maidaSeaspine holdings corpGlobus medical incCompany analysisNuvasive incOrthopediatrics corpOrthofix medical incArthrex incSurgical incStryker corpXtant medical incTechnavio researchCompany profileSolutions group plc

Affimed N : Form 6-K -November 30, 2023 at 07:05 am EST

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K .

United statesAngus smithArndt schotteliusAdi hoessHarry weltenCompany or affimedChief financial officerChief scientific officerSupervisory boardKuros biosciencesCytos biotechnologyHorizon pharmaNitec pharmaChief executive officerSupervisory boards